The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
Asthma: Drug combo leaves many with uncontrolled disease Many people who take inhaled steroids combined with long-acting β2-agonist drugs still have poorly controlled asthma. A team led by Ian Pavord from the University of Oxford, UK, identified 701 people from the 2010–2011 UK National Health and W...
Guardado en:
Autores principales: | Ian D. Pavord, Nicola Mathieson, Anna Scowcroft, Riccardo Pedersini, Gina Isherwood, David Price |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d36bb18ba614775b04b5f1fea03b7ec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan
por: Cheng-Yi Wang, et al.
Publicado: (2021) -
Perceptions of asthma control in the United Kingdom: a cross-sectional study comparing patient and healthcare professionals’ perceptions of asthma control with validated ACT scores
por: Andrew Menzies-Gow, et al.
Publicado: (2017) -
Influence of the first wave of COVID-19 on asthma inhaler prescriptions
por: C. I. Bloom, et al.
Publicado: (2021) -
Dynamics of inhaled corticosteroid use are associated with asthma attacks
por: Joy Lee, et al.
Publicado: (2021) -
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
por: Priyadarshini Kachroo, et al.
Publicado: (2021)